Literature DB >> 8174498

Performance, subjective, and physiological effects of nicotine in non-smokers.

S J Heishman1, F R Snyder, J E Henningfield.   

Abstract

Sixteen human volunteers with little or no experience using tobacco participated in one 4.5-h experimental session in which they were administered three doses of nicotine polacrilex gum (0, 2 and 4 mg) in ascending order at 90-min intervals. Physiological, subjective, and cognitive performance measures were assessed before and after each dose. Nicotine produced dose-related increases in heart rate and blood pressure and decreases in skin temperature. Nicotine also increased subjective ratings of dose strength and negative effects and decreased ratings of desire to repeat the same dose. There were dose-related trends toward decreased accuracy and increased response time on 3 of the 4 cognitive tests. These data do not support the hypothesis that nicotine enhances cognitive functioning in non-smokers.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8174498     DOI: 10.1016/0376-8716(93)90041-n

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  23 in total

Review 1.  Cognitive effects of nicotine: genetic moderators.

Authors:  Aryeh I Herman; Mehmet Sofuoglu
Journal:  Addict Biol       Date:  2010-04-29       Impact factor: 4.280

2.  The nicotinic acetylcholine receptor alpha5 subunit plays a key role in attention circuitry and accuracy.

Authors:  Craig D C Bailey; Mariella De Biasi; Paul J Fletcher; Evelyn K Lambe
Journal:  J Neurosci       Date:  2010-07-07       Impact factor: 6.167

3.  Working memory in cigarette smokers: comparison to non-smokers and effects of abstinence.

Authors:  Adrianna Mendrek; John Monterosso; Sara L Simon; Murray Jarvik; Arthur Brody; Richard Olmstead; Catherine P Domier; Mark S Cohen; Monique Ernst; Edythe D London
Journal:  Addict Behav       Date:  2005-07-11       Impact factor: 3.913

Review 4.  Schizophrenia and tobacco smoking comorbidity: nAChR agonists in the treatment of schizophrenia-associated cognitive deficits.

Authors:  Manoranjan S D'Souza; Athina Markou
Journal:  Neuropharmacology       Date:  2011-02-01       Impact factor: 5.250

5.  Transdermal nicotine administration and the electroencephalographic activity of substance abusers in treatment.

Authors:  Natalie A Ceballos; Rick Tivis; Robert Prather; Sara Jo Nixon
Journal:  J Addict Med       Date:  2008       Impact factor: 3.702

6.  Acute effects of snus in never-tobacco users: a pilot study.

Authors:  Jenny E Ozga; Nicholas J Felicione; Daniel Elswick; Melissa D Blank
Journal:  Am J Drug Alcohol Abuse       Date:  2016-12-08       Impact factor: 3.829

7.  C957T polymorphism of the dopamine D2 receptor gene modulates the effect of nicotine on working memory performance and cortical processing efficiency.

Authors:  Leslie K Jacobsen; Kenneth R Pugh; W Einar Mencl; Joel Gelernter
Journal:  Psychopharmacology (Berl)       Date:  2006-08-09       Impact factor: 4.530

8.  Performance effects of nicotine during selective attention, divided attention, and simple stimulus detection: an fMRI study.

Authors:  Britta Hahn; Thomas J Ross; Frank A Wolkenberg; Diaa M Shakleya; Marilyn A Huestis; Elliot A Stein
Journal:  Cereb Cortex       Date:  2008-12-10       Impact factor: 5.357

9.  Nicotine enhances visuospatial attention by deactivating areas of the resting brain default network.

Authors:  Britta Hahn; Thomas J Ross; Yihong Yang; Insook Kim; Marilyn A Huestis; Elliot A Stein
Journal:  J Neurosci       Date:  2007-03-28       Impact factor: 6.167

10.  Haemodynamic reactions to acute psychological stress and smoking status in a large community sample.

Authors:  Anna C Phillips; Geoff Der; Kate Hunt; Douglas Carroll
Journal:  Int J Psychophysiol       Date:  2009-05-04       Impact factor: 2.997

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.